American Association of Clinical Endocrinologists Applauds American Medical Association for Obesity Education Resolution

JACKSONVILLE, Fla. – June 11, 2015 – The American Association of Clinical Endocrinologists (AACE) secured approval of a resolution by the American Medical Association (AMA) House of Delegates that will that will secure  the study of obesity education in medical schools and the develop recommendations to address gaps in obesity education to physicians.

The resolution was also supported by the American Society of Bariatric Physicians and the Endocrine Society and approved was at the AMA meeting in Chicago this week.

The AMA first agreed with AACE in 2013 when it recognized obesity as a disease state with multiple pathophysiological aspects that require a range of interventions. Obesity is a risk factor for other chronic diseases such as type 2 diabetes, hypertension and cardiovascular disease.  

AACE is at the forefront of the obesity epidemic, developing a plan of action to tackle the various modalities of obesity management, including behavioral, nutritional, pharmacological and surgical interventions.

In March 2014, AACE convened a groundbreaking Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action with stakeholders in the biomedical, governmental, health industry and medical and educational societies. An advanced framework for a new medically-actionable diagnosis of obesity was conceived.

Furthermore, AACE has introduced a toolkit for obesity medicine to serve as a guide for primary care physicians and evidence based guidelines are being developed.

About the American Association of Clinical Endocrinologists (AACE)
The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in endocrinology, diabetes and metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. Visit our website at